Clinical trials
Phase 1 Arthritis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 5 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Terminated | 5 |
| Unknown status | 4 |
| Not yet recruiting | 3 |
| Recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| POZEN | 4 |
| Bristol-Myers Squibb | 3 |
| MedImmune LLC | 2 |
| PMG Pharm Co., Ltd | 2 |
| R3 Stem Cell | 2 |
| Amgen | 1 |
| Arthrogen | 1 |
| AstraZeneca | 1 |
| Biosolution Co., Ltd. | 1 |
| Calibr, a division of Scripps Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis | 44 |
| Arthritis, Rheumatoid | 15 |
| Joint Diseases | 7 |
| Musculoskeletal Diseases | 6 |
| Osteoarthritis | 5 |
| Rheumatic Diseases | 5 |
| Autoimmune Diseases | 4 |
| Connective Tissue Diseases | 4 |
| Immune System Diseases | 4 |
| Lupus Erythematosus, Systemic | 4 |
Trials
Showing 51 to 44 of 44. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.